Beyond Air (XAIR) Net Shares Issued and Repurchased (2017 - 2026)
Beyond Air's (XAIR) quarterly Net Shares Issued and Repurchased came in at $25750.0 in Q2 2026, down 93.63% year-over-year from $404250.0 in Q2 2025, and down 95.42% quarter-over-quarter from $561750.0 in Q1 2026.
Analysis
Beyond Air (XAIR) Net Shares Issued and Repurchased (2017 - 2026) Analysis & Trends
Beyond Air has disclosed Net Shares Issued and Repurchased across 10 years of filings, most recently posting $25750.0 for Q2 2026.
- In Q2 2026, Net Shares Issued and Repurchased fell 93.63% year-over-year to $25750.0; the TTM figure through Jun 2026 stood at $25750.0 (down 93.63% YoY), while the FY2026 annual figure was $561750.0, down 54.11% from the prior year.
- Net Shares Issued and Repurchased came in at $25750.0 for Q2 2026 at Beyond Air, down from $561750.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.7 million in Q1 2022 to a low of $6800.0 in Q2 2023.
- Average Net Shares Issued and Repurchased over 5 years is $424251.4, with a median of $138962.5 recorded in 2024.
- Year-over-year, Net Shares Issued and Repurchased slumped 99.5% in 2023 and jumped 2019.49% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $60000.0 in 2022, then slumped by 88.67% to $6800.0 in 2023, then jumped by 2019.49% to $144125.0 in 2024, then soared by 180.49% to $404250.0 in 2025, then sank by 93.63% to $25750.0 in 2026.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $25750.0 in Q2 2026, $561750.0 in Q1 2026, and $404250.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.67 Bn | 175.07 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.14 Bn | 108.32 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.81 Bn | 100.34 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.52 Bn | 62.98 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | - |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | - |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | 25,750.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25,750.00 |
| Mar 31, 2026 | 561,750.00 |
| Jun 30, 2025 | 404,250.00 |
| Mar 31, 2025 | 1.22 Mn |
| Jun 30, 2024 | 144,125.00 |
| Mar 31, 2024 | 133,800.00 |
| Jun 30, 2023 | 6,800.00 |
| Mar 31, 2023 | 8,400.00 |
| Jun 30, 2022 | 60,000.00 |
| Mar 31, 2022 | 1.67 Mn |
| Jun 30, 2021 | 8,000.00 |
| Mar 31, 2021 | 1.13 Mn |
| Jun 30, 2020 | 122,000.00 |
| Mar 31, 2020 | 815,000.00 |
| Jun 30, 2019 | 14,475.00 |
| Mar 31, 2019 | 1.92 Mn |
| Jun 30, 2018 | 245,781.00 |
| Dec 31, 2017 | 844,000.00 |
| Jun 30, 2017 | 246,312.00 |
| Mar 31, 2017 | 150,000.00 |